Pricing
Login
Home
Charts
Search
Watchlist
Products

Dishman Carbogen Amcis Ltd

DCAL
₹115.57-2.50%20 Nov 2026
Reports
Pharma CRAMS

Dishman Carbogen Amcis Ltd

DCAL
₹115.57
-2.50%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,812Cr
Close
Close Price
₹115.57
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
—
PS
Price To Sales
0.66
Revenue
Revenue
₹2,756Cr
Rev Gr TTM
Revenue Growth TTM
-0.11%
PAT Gr TTM
PAT Growth TTM
-184.93%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
651655524789682716708653720851678507
Growth YoY
Revenue Growth YoY%
1.85.8-27.634.54.89.435.2-17.35.518.9-4.3-22.3
Expenses
ExpensesCr
610592495642542564567504607688618461
Operating Profit
Operating ProfitCr
4163291471401531411491131636046
OPM
OPM%
6.39.65.518.620.521.319.922.815.719.18.99.1
Other Income
Other IncomeCr
64-448-4228715164
Interest Expense
Interest ExpenseCr
333132374942434246433740
Depreciation
DepreciationCr
808571727279818484899190
PBT
PBTCr
-66-49-784227283931-1046-51-81
Tax
TaxCr
-7210922-1515-353247-14
PAT
PATCr
-60-70-78335432365-1322-58-67
Growth YoY
PAT Growth YoY%
-227.01.1-556.3180.9107.8161.6130.297.3-380.1-49.5-347.2-202.2
NPM
NPM%
-9.2-10.7-14.84.20.76.03.310.0-1.82.5-8.5-13.2
EPS
EPS₹
-3.8-4.5-5.02.10.32.81.54.2-0.81.4-3.7-4.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
651655524789682716708653720851678507
Growth YoY
Revenue Growth YoY%
1.85.8-27.634.54.89.435.2-17.35.518.9-4.3-22.3
Expenses
ExpensesCr
610592495642542564567504607688618461
Operating Profit
Operating ProfitCr
4163291471401531411491131636046
OPM
OPM%
6.39.65.518.620.521.319.922.815.719.18.99.1
Other Income
Other IncomeCr
64-448-4228715164
Interest Expense
Interest ExpenseCr
333132374942434246433740
Depreciation
DepreciationCr
808571727279818484899190
PBT
PBTCr
-66-49-784227283931-1046-51-81
Tax
TaxCr
-7210922-1515-353247-14
PAT
PATCr
-60-70-78335432365-1322-58-67
Growth YoY
PAT Growth YoY%
-227.01.1-556.3180.9107.8161.6130.297.3-380.1-49.5-347.2-202.2
NPM
NPM%
-9.2-10.7-14.84.20.76.03.310.0-1.82.5-8.5-13.2
EPS
EPS₹
-3.8-4.5-5.02.10.32.81.54.2-0.81.4-3.7-4.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,2721,7141,6952,0592,0441,9122,1412,4132,6162,7122,9322,756
Growth
Revenue Growth%
13.2-1.121.5-0.7-6.412.012.78.43.78.1-0.1
Expenses
ExpensesCr
9821,2601,2491,5071,5461,6381,8092,0812,3292,2432,3662,374
Operating Profit
Operating ProfitCr
290453445552498274331332287469566382
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.313.9
Other Income
Other IncomeCr
18254654441629-202245242
Interest Expense
Interest ExpenseCr
7949495762485786120159174166
Depreciation
DepreciationCr
84214211240283308308281311294339354
PBT
PBTCr
145216231309197-65-4-55-12219105-97
Tax
TaxCr
4571769839100-22-253116719
PAT
PATCr
100145155210159-16518-30-153397-116
Growth
PAT Growth%
76.76.336.1-24.6-204.2110.9-265.5-414.9102.12,907.7-184.9
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.3-4.2
EPS
EPS₹
12.49.09.613.010.1-10.51.1-1.9-9.80.26.2-7.4
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,2721,7141,6952,0592,0441,9122,1412,4132,6162,7122,9322,756
Growth
Revenue Growth%
13.2-1.121.5-0.7-6.412.012.78.43.78.1-0.1
Expenses
ExpensesCr
9821,2601,2491,5071,5461,6381,8092,0812,3292,2432,3662,374
Operating Profit
Operating ProfitCr
290453445552498274331332287469566382
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.313.9
Other Income
Other IncomeCr
18254654441629-202245242
Interest Expense
Interest ExpenseCr
7949495762485786120159174166
Depreciation
DepreciationCr
84214211240283308308281311294339354
PBT
PBTCr
145216231309197-65-4-55-12219105-97
Tax
TaxCr
4571769839100-22-253116719
PAT
PATCr
100145155210159-16518-30-153397-116
Growth
PAT Growth%
76.76.336.1-24.6-204.2110.9-265.5-414.9102.12,907.7-184.9
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.3-4.2
EPS
EPS₹
12.49.09.613.010.1-10.51.1-1.9-9.80.26.2-7.4
Sales CAGR
1 Year8%
3 Years7%
5 Years9%
TTM0%
EBITDA CAGR
1 Year21%
3 Years19%
5 Years16%
TTM-34%
PAT CAGR
1 Year2908%
3 Years-
5 Years-
TTM-
Avg. ROCE
1 Year3%
3 Years2%
5 Years1%
TTM1%
CFO / EBITDA
1 Year87%
3 Years94%
5 Years94%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
16032323131313131313131
Reserves
ReservesCr
1,0154,8145,0755,3475,6845,6675,5185,7785,5965,8006,6466,640
Current Liabilities
Current LiabilitiesCr
6779941,1781,1981,5691,2901,4201,7982,5551,9252,3172,721
Non Current Liabilities
Non Current LiabilitiesCr
5797868917519161,3771,6691,8451,3992,2432,9292,404
Total Liabilities
Total LiabilitiesCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,92311,796
Current Assets
Current AssetsCr
6731,3331,5461,5541,7791,7041,8391,9181,9282,2002,8423,014
Non Current Assets
Non Current AssetsCr
1,6185,2605,6305,7756,4216,6626,7997,5357,6537,7999,0818,782
Total Assets
Total AssetsCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,92311,796
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
16032323131313131313131
Reserves
ReservesCr
1,0154,8145,0755,3475,6845,6675,5185,7785,5965,8006,6466,640
Current Liabilities
Current LiabilitiesCr
6779941,1781,1981,5691,2901,4201,7982,5551,9252,3172,721
Non Current Liabilities
Non Current LiabilitiesCr
5797868917519161,3771,6691,8451,3992,2432,9292,404
Total Liabilities
Total LiabilitiesCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,92311,796
Current Assets
Current AssetsCr
6731,3331,5461,5541,7791,7041,8391,9181,9282,2002,8423,014
Non Current Assets
Non Current AssetsCr
1,6185,2605,6305,7756,4216,6626,7997,5357,6537,7999,0818,782
Total Assets
Total AssetsCr
2,2916,5937,1767,3288,2008,3668,6379,4549,5819,99911,92311,796

Cash Flow

Consolidated
Standalone
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
137303226282585513355266379371491
Investing Cash Flow
Investing Cash FlowCr
-90-142-297-169-442-380-619-494-230-192-245
Financing Cash Flow
Financing Cash FlowCr
-50-13778-102-98-11130250-22-102201
Net Cash Flow
Net Cash FlowCr
-32371146122-1332212877447
Free Cash Flow
Free Cash FlowCr
3216422-26177147-101-35276156225
CFO To PAT
CFO To PAT%
136.9208.1146.5134.1369.1-310.51,970.3-892.5-247.311,459.3504.3
CFO To EBITDA
CFO To EBITDA%
47.366.850.951.1117.6186.9107.180.1132.479.286.9
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
137303226282585513355266379371491
Investing Cash Flow
Investing Cash FlowCr
-90-142-297-169-442-380-619-494-230-192-245
Financing Cash Flow
Financing Cash FlowCr
-50-13778-102-98-11130250-22-102201
Net Cash Flow
Net Cash FlowCr
-32371146122-1332212877447
Free Cash Flow
Free Cash FlowCr
3216422-26177147-101-35276156225
CFO To PAT
CFO To PAT%
136.9208.1146.5134.1369.1-310.51,970.3-892.5-247.311,459.3504.3
CFO To EBITDA
CFO To EBITDA%
47.366.850.951.1117.6186.9107.180.1132.479.286.9

Ratios

Consolidated
Standalone
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,1743,3808411,7092,9031,9553,6943,4122,0381,812
Price To Earnings
Price To Earnings
33.516.15.3161.01,036.220.9
Price To Sales
Price To Sales
3.01.60.40.91.40.81.41.30.70.7
Price To Book
Price To Book
1.00.60.10.30.50.30.70.60.30.3
EV To EBITDA
EV To EBITDA
13.57.53.810.913.812.019.511.37.310.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.477.473.473.270.168.470.969.667.273.478.578.5
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.313.9
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.3-4.2
ROCE
ROCE%
12.24.74.65.83.7-0.20.70.40.02.22.90.7
ROE
ROE%
9.73.03.03.92.8-2.90.3-0.5-2.70.11.5-1.7
ROA
ROA%
4.42.22.12.91.9-2.00.2-0.3-1.60.00.8-1.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2013Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,1743,3808411,7092,9031,9553,6943,4122,0381,812
Price To Earnings
Price To Earnings
33.516.15.3161.01,036.220.9
Price To Sales
Price To Sales
3.01.60.40.91.40.81.41.30.70.7
Price To Book
Price To Book
1.00.60.10.30.50.30.70.60.30.3
EV To EBITDA
EV To EBITDA
13.57.53.810.913.812.019.511.37.310.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.477.473.473.270.168.470.969.667.273.478.578.5
OPM
OPM%
22.826.426.326.824.414.315.513.810.917.319.313.9
NPM
NPM%
7.98.59.110.27.8-8.60.8-1.2-5.90.13.3-4.2
ROCE
ROCE%
12.24.74.65.83.7-0.20.70.40.02.22.90.7
ROE
ROE%
9.73.03.03.92.8-2.90.3-0.5-2.70.11.5-1.7
ROA
ROA%
4.42.22.12.91.9-2.00.2-0.3-1.60.00.8-1.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr5,5952,7221,9841,812230149128
Close PriceClose₹977.80220.76961.25115.57207.00135.00158.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE33.5630.4117.5417.2617.34
Price To SalesPS3.001.472.190.662.281.091.83
RevenueRevenueCr1,8651,8519042,75610113770
Revenue Growth TTMRev Gr TTM%36.8%8.9%19.0%-0.1%22.3%54.7%
PAT Growth TTMPAT Gr TTM%34.0%-149.5%8.9%-184.9%44.5%-3.4%
Market CapitalizationMkt CapCr5,5952,7221,9841,812230149128
Close PriceClose₹977.80220.76961.25115.57207.00135.00158.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE33.5630.4117.5417.2617.34
Price To SalesPS3.001.472.190.662.281.091.83
RevenueRevenueCr1,8651,8519042,75610113770
Revenue Growth TTMRev Gr TTM%36.8%8.9%19.0%-0.1%22.3%54.7%
PAT Growth TTMPAT Gr TTM%34.0%-149.5%8.9%-184.9%44.5%-3.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Interviews